Author Archive

HomeAuthor's Article(s) linglong

歡迎收聽《CRIF談永續》,本集邀請到臺灣碳權交易所總經理 田建中,帶大家深入認識碳交易的真相與未來!當「氣候變遷因應法」上路、碳費即將開徵,許多企業開始焦慮該如何應對減碳壓力。但你知道嗎?碳交易其實不只是成本控管,更可能是企業搶進國際市場的新機會!

面對中美貿易戰、全球政經變局與碳中和壓力,許多台灣企業的第二代正在接下重擔──但接班不是接炸彈,關鍵在於是否找到「數位+永續」的突圍策略。本集《CRIF談永續》邀請到臺灣數位企業總會執行長 Bella,分享她如何帶領眾多二代企業家,一起面對數位轉型與ESG融合的新挑戰。

In order to continue to expand its operations, Sangtat Chemical has obtained international drug certificates through research and development, and is preparing for mass production in the international market. In 2024, Sangtat Chemical will add new hardware and software equipment to reduce energy consumption and provide diversified care to accompany school-age youths to attend school without fear, so as to improve the enterprise's physical quality to face the fierce competition in the world, and to lay out the plan for a hundred years of sustainable operation. Sustainable operation.

In today's world, where sustainability is paramount, whether you're a business owner, investor, or simply interested in corporate social responsibility, understanding key ESG terminology can help you keep pace with global developments. This article will explain some common and important ESG terms to help you get started easily and enhance your competitiveness. Whether you're new to this field or looking to deepen your understanding of ESG management, this ESG glossary will help you master it quickly!

In the face of the challenges of global climate change, the COP meetings have always been central to global cooperation. Since COP1 in 1995, cooperation and commitments among countries have gradually strengthened. From the Kyoto Protocol to the Paris Agreement, each discussion and agreement has propelled the development of global climate policy. This article will review key meetings from COP1 to COP28, explore how they have influenced global ESG policy, and provide concrete guidelines for businesses to take carbon reduction actions.

In addition to strengthening environmental protection spending by adopting solar green electricity and successfully passing ISO 14064-1 and ISO 14067 certifications in recent years, Taiyao has also made significant progress in ESG initiatives, including a three-year consecutive decline in process water consumption and a continued increase in recycled water volume. Furthermore, it has established a caring and supportive work environment, and its R&D investment has increased for three consecutive years, with its proportion of revenue also expanding. Besides its CDMO business contributing revenue to multiple countries, Taiyao continues to contribute to the healthcare sector, demonstrating its commitment to corporate sustainability.

Polaris Pharmaceuticals focuses on developing metabolic therapy drugs for cancer to alleviate patient discomfort and reduce side effects. In 2022, the company achieved a milestone by completing its clinical trial for lung mesothelioma, and several of its cancer drugs have entered Phase III clinical trials, moving towards obtaining drug approvals in various countries. In addition, the company undertakes contract development and manufacturing organization (CDMO) services for biopharmaceuticals, and its R&D investment has been increasing year by year. In the future, it will implement an automated management system to monitor energy consumption.

Sinochem Holdings has long encouraged Taiwanese people to engage in biotechnology and pharmaceutical research and new drug development. Through new drug licensing, it not only expands the application areas but also promotes public health. Regarding process wastewater management, Sinochem Holdings complies with regulations and minimizes ecological risks. It also operates mobile health vehicles to rural areas to care for the elderly, demonstrating the company's commitment to sustainability. In 2023, Sinochem Pharmaceuticals achieved significant results in the pharmaceutical field, independently developing nine new products covering a variety of drugs.